Sri Lankan Health Ministry Suspended Rubella Vaccination Programme After The Death Of A Girl Student
Ministry Of Health in Colombo today Temporary Suspended the Rubella Vaccination Programme after a Girl Student of Matara in the Southern Sri Lanka who was Hospitalized for Allergic Condition after receiving the Vaccine Died Yesterday Night.Ministry was taken this action according to the Advise of President Mahinda Rajapaksha Ministry Sources said.
Director General Of Health Services Dr.Ajith Mendis Under a Special Circular issued to the Family Health Bureau and MOH Offices today instructed to stop Rubella Vaccination Programme with Immediate effect.The Girl Student who developed Allergic Symptoms like Vomitting and Headache was in Ventilator of the Intensive Care Unit(ICU) of Matara General Hospital and she died yesterday night. Another 24 Girl Students of the same school were received treatment from the Matara General Hospital and 20 of them were discharged this evening according to the Hospital Sources
Meanwhile A Special Team of Doctors compromising Three Epidemiologists and the Deputy Director General of Health Services(Public Health) Dr.P.Maheepala went to Matara MOH this morning under the instructions of Health Minister Nimal Siripala De Silva to probe on the Rubella Vaccination Incident.The team is due to produce a Full Report on the incident to the Health Secretary Dr.Athula Kahanda Liyanage this evening.
Ministry Of Health also decided to bring a Specialist from the World Health Organization(WHO) to conduct a special probe on the incident.
"Rubella Vaccination Programme was introduced to Sri Lanka's National Immunization Programme in the year 1996 and since then this is the first time this kind of incident was reported" according to the Health Ministry Sources.President Mahinda Rajapaksha ordered to release Rs.Five Laks for the Parents of the Deceased Girl Student from the Presidents Fund.The Girl was the only child of her family.
Tags: Rubella Vaccination Progr , Health
This work is licensed under a Creative Commons Attribution-No Derivative Works 3.0 License.